Document Detail


Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.
MedLine Citation:
PMID:  9541435     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To assess the value of scintigraphy with [123I]N-(2-diethylaminoethyl)-4-iodobenzamide (BZA), a phase II clinical trial was performed on 48 patients with a suspicion of ocular melanoma. METHODS: 56 examinations were performed to image lesions with a clinical diagnosis of primary ocular melanoma before and/or after treatment, to observe the results in simulating lesions or to image metastases. RESULTS: Ocular BZA-scintigraphy demonstrated a sensitivity of 86%, and a specificity of 83%. Whole-body scintigraphy was used in the follow-up of treated patients and could be repeated. We imaged orbital recurrence, known and occult metastases, specially in the liver. After 9 conservative treatments ocular BZA-scintigraphy was negative in 9 eyes. CONCLUSION: The BZA-scintigraphy in combination with other diagnostic procedures appeared to be a suitable method in the diagnosis of ocular melanoma and a potentially useful imaging modality to screen for ocular malignant melanoma metastases.
Authors:
F Bacin; J Michelot; J Bonafous; A Veyre; M F Moreau; J L Kemeny; F Chossat; D Bekhechi
Related Documents :
17634845 - The role of tc-99m (v) dmsa scintigraphy in the diagnosis and follow-up of lung cancer ...
21413075 - Influence of the fid and off-resonance effects in dense mri.
22473235 - Large deep venous anomaly presenting as a left frontal lesion.
2565175 - The radionuclide assessment of a system for slow intrathecal infusion of drugs.
2243985 - Association of vertebral end plate fracture with pediatric lumbar intervertebral disk h...
10775955 - Encephalitis, cerebritis, and brain abscess: pathophysiology and imaging findings.
Publication Detail:
Type:  Clinical Trial; Clinical Trial, Phase II; Journal Article    
Journal Detail:
Title:  Acta ophthalmologica Scandinavica     Volume:  76     ISSN:  1395-3907     ISO Abbreviation:  Acta Ophthalmol Scand     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-05-05     Completed Date:  1998-05-05     Revised Date:  2008-03-17    
Medline Journal Info:
Nlm Unique ID:  9507578     Medline TA:  Acta Ophthalmol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  56-61     Citation Subset:  IM    
Affiliation:
CHU Gabriel Montpied, Service d'Ophtalmologie, Clermont-Ferrand, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Benzamides / diagnostic use*
Brachytherapy
Conjunctival Neoplasms / pathology,  radionuclide imaging*,  therapy
Contrast Media*
Eye Enucleation
Female
Humans
Laser Coagulation
Liver Neoplasms / radionuclide imaging*,  secondary,  therapy
Lung Neoplasms / radionuclide imaging*,  secondary,  therapy
Male
Melanoma / radionuclide imaging*,  secondary,  therapy
Middle Aged
Sensitivity and Specificity
Uveal Neoplasms / pathology,  radionuclide imaging*,  therapy
Chemical
Reg. No./Substance:
0/Benzamides; 0/Contrast Media; 106790-96-9/N-(2-(diethylamino)ethyl)-4-iodobenzamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visual Ability Score -- a new method to analyze ability in visually impaired children.
Next Document:  Whole blood selenium in exudative age-related maculopathy.